Random

tissue plasminogen activator

·April 6, 2020·3 min read

Anti-clotting drug could reduce ARDS deaths as a result of COVID-19

A new clinical trial is being established to see if anti-clotting drugs, commonly used for heart attack and stroke patients, can help treat COVID-19 patients who develop ARDS. If successful, the tPA drugs could help alleviate the expected ventilator shortage problem we are likely to experience soon.

The diagram shows the different types of brain strokes.

Featured Neurology

·October 24, 2013·3 min read

Experimental Drug Reduces Brain Damage in Rodents

An experimental drug appears to reduce brain damage, improve motor skills and eliminate hemorrhaging in older stroke afflicted rodents.

Featured Neurology Neuroscience

·October 12, 2020·5 min read

Improvements in Stroke Treatment Could Save More Lives

Direct carotid puncture is a safe and effective alternative to thrombectomy for stroke patients.

Featured Neurology

·June 11, 2012·3 min read

New Stroke Treatment Could Prevent and Reduce Brain Damage

Findings show new therapy has potential to help the brain as it reacts to stroke’s harmful effects. Researchers at the...

Featured Neurology Neuroscience Open Neuroscience Articles

·May 4, 2020·2 min read

Stroke clot-buster drugs could be harnessed to tackle COVID-19

An aerosolized version of tissue plasminogen activator (tPA), a clot-busing drug commonly used for the treatment of stroke patients, could target blood clots that form as a result of severe coronavirus infection.

This image shows how a hemorrhagic stroke can occur in the brain.

Featured Neurology Neuroscience Videos

·February 11, 2015·4 min read

Anti Epilepsy Drug Preserves Brain Function After Stroke

A new study reports an anti-epilepsy drug could reduce the debilitating impact of strokes.

Featured Neuroscience

·March 24, 2020·5 min read

Repurposing blood clot drug could help treat COVID-19

Tissue plasminogen activators (tPA), FDA approved drugs used to treat stroke and heart attack patients, may help COVID-19 patients in danger of respiratory failure. If successful, the drug may help treat severe respiratory symptoms when ventilators are not available.

Featured Genetics Neurology Neuroscience Business

·July 17, 2012·3 min read

Experimental Drug May Extend Therapeutic Window for Stroke

An experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally approved clot-busting therapy has been created.